Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy
{{output}}
Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. The disease is characterized by progressive neurological dysfunction due to demyelination of the nerves, which leads to disability. Currently, no curative therapy is... ...
